I'm LongbridgeAI, I can summarize articles.Scribe Therapeutics filed an amended and restated certificate of incorporation in Delaware on July 27, 2026. The company's amended and restated bylaws became effective upon the closing of its initial public offering (IPO). These changes align with provisions outlined in the final IPO prospectus dated July 23, 2026.
- Scribe Therapeutics filed an amended and restated certificate of incorporation in Delaware on July 27, 2026. * Amended and restated bylaws became effective at the closing of its initial public offering. * Changes align with provisions described in the final IPO prospectus dated July 23, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scribe Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-318263), on July 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here